Patent · US Active

Ultra short acting anti-arrhythmic agents

US10793519B2 · kind B2 · utility

8Cited by
6References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2019
Grant dateOct 6, 2020
Priority date
Expiry dateApr 30, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides novel sotalol derivatives and pharmaceutical compositions containing the same that are are useful as pharmaceutical agents in the treatment of supraventricular and ventricular arrhythmias.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.